Top Sell
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.53 | - | - |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.86 | €6.49 | 652.553% |
| Ocuphire Pharma Inc. | 6 | 1 | 0 | 0 | €1.46 | €18.37 | 1157.945% |
| Immuron | 0 | 1 | 0 | 0 | €2.08 | - | - |
| Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €3.02 | €7.31 | 141.986% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.22 | - | - |
| Medigene AG | 1 | 1 | 0 | 0 | €1.17 | - | - |
| Amarin Corp. ADR | 2 | 2 | 0 | 0 | €0.66 | - | - |
| Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €10.60 | €22.00 | 107.547% |
| Sangamo Therapeutics Inc. | 12 | 12 | 0 | 0 | €0.36 | €3.63 | 902.818% |
| Bristol-Myers Squibb | 12 | 3 | 0 | 0 | €39.23 | €70.25 | 79.101% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.20 | €50.00 | 38.122% |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.15 | €50.00 | 4266.812% |
| Moleculin Biotech Inc | 3 | 24 | 0 | 1 | €0.41 | €18.42 | 4393.659% |
| CEL-SCI Corp. | 0 | 1 | 0 | 0 | €1.14 | - | - |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €1.17 | - | - |
| Bayer AG ADR | 1 | 1 | 0 | 0 | €6.25 | €7.00 | 12.000% |
| Evoke Pharma Inc. | 0 | 23 | 0 | 0 | €0.46 | - | - |
| Cara Therapeutics Inc. | 11 | 5 | 0 | 3 | €0.26 | €4.61 | 1673.287% |
| Akebia Therapeutics Inc. | 7 | 2 | 0 | 0 | €0.95 | €3.64 | 284.025% |
| Bellicum Pharmaceuticals Inc. | 0 | 12 | 0 | 0 | €0.064 | - | - |
| Palatin Technologies Inc. | 0 | 4 | 0 | 0 | €1.77 | - | - |
| Novan Inc | 0 | 24 | 0 | 0 | €0.001 | - | - |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 0 | 1 | 0 | 0 | €2.22 | - | - |